Two physiologically based pharmacokinetic models for trichloroethylene (TCE
) in mice and humans were calibrated with new toxicokinetic data sets. Cali
bration is an important step in model development, essential to a legitimat
e use of models for research or regulatory purposes. A Bayesian statistical
framework was used to combine prior information about the model parameters
with the data likelihood to yield posterior parameter distributions for mi
ce, these distributions represent uncertainty. For humans, the use of a pop
ulation statistical model yielded estimates of both variability and uncerta
inty in human toxicokinetics of TCE. After adjustment of the models by Mark
ov chain Monte Carlo sampling, the mouse model agreed with a large part of
the data. Yet, some data on secondary metabolites were not fit well. The po
sterior parameter distributions obtained for mice were quite narrow(coeffic
ient of variation [CV] of about 10 or 20%), but these CVs might be underest
imated because of the incomplete fit of the model. The data fit, for humans
, was better than for mice. Yet, some improvement of the model is needed to
correctly describe trichloroethanol concentrations over long time periods.
Posterior uncertainties about the population means corresponded to 10-20%
CV. In terms of human population variability, volumes and flows varied acro
ss subject by approximately 20% CV. The variability was somewhat higher for
partition coefficients (between 30 and 40%) and much higher for the metabo
lic parameters (standard deviations representing about a factor of 2). Fina
lly, the analysis points to differences between human males and females in
the toxicokinetics of TCE. The significance of these differences in terms o
f risk remains to be investigated.